Yüklüyor......
Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified?
The outbreak of COVID-19 in Wuhan, China and its declaration as a global pandemic by WHO has left the medical community under significant pressure to rapidly identify effective therapeutic and preventative strategies. Chloroquine (CQ) and its analogue hydroxychloroquine (HCQ) were found to be effica...
Kaydedildi:
| Yayımlandı: | Open Heart |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7440188/ https://ncbi.nlm.nih.gov/pubmed/32817375 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2020-001362 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|